Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer

Saved in:
Bibliographic Details
Published in:British journal of cancer 2016-10, Vol.115 (9), p.e16-e16
Main Authors: Dalgleish, Angus G, Stebbing, Justin, Adamson, Douglas J A, Arif, Seema Safia, Bidoli, Paolo, Chang, David, Cheeseman, Sue, Diaz-Beveridge, Robert, Fernandez-Martos, Carlos, Glynne-Jones, Rob, Granetto, Cristina, Massuti, Bartomeu, McAdam, Karen, McDermott, Raymond, Martín, Andrés J Muñoz, Papamichael, Demetris, Pazo-Cid, Roberto, Vieitez, Jose M, Zaniboni, Alberto, Carroll, Kevin J, Wagle, Shama, Gaya, Andrew, Mudan, Satvinder S
Format: Article
Language:English
Subjects:
Corrigendum
Pancreatic cancer
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0007-0920
1532-1827
DOI:10.1038/bjc.2016.342